The American journal of otology · 1998
Otalgia. An isolated symptom of malignant infratemporal tumors.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Leonetti J P, Li J, Smith P G
Аннотация
OBJECTIVE: This study aimed to review a series of 18 patients with malignant infratemporal fossa tumors who presented with otalgia as the primary symptom.
STUDY DESIGN: This was a retrospective case analysis.
SETTING: All patients were evaluated and treated at a tertiary care academic medical institution.
PATIENTS: Eighteen patients evaluated for otalgia in a normal-appearing ear, between July 1988 and July 1996, who were found to have a malignant infratemporal fossa tumor participated.
INTERVENTIONS: Diagnostic testing included radiographic evaluations and tissue sampling through fine-needle aspiration cytology. Treatment methods were histology dependent.
MAIN OUTCOME MEASURES: The time between the onset of otalgia and the tumor diagnosis was recorded. Overall treatment outcomes were reviewed.
RESULTS: The period between the onset of otalgia and tumor diagnosis ranged from 4-21 months with a mean of 7.5 months. Adenoid cystic carcinoma was the most commonly seen tumor in this series of patients.
CONCLUSIONS: The infratemporal fossa is a relatively protected region that may be the site of malignant neoplasms causing the isolated symptom of otalgia.
STUDY DESIGN: This was a retrospective case analysis.
SETTING: All patients were evaluated and treated at a tertiary care academic medical institution.
PATIENTS: Eighteen patients evaluated for otalgia in a normal-appearing ear, between July 1988 and July 1996, who were found to have a malignant infratemporal fossa tumor participated.
INTERVENTIONS: Diagnostic testing included radiographic evaluations and tissue sampling through fine-needle aspiration cytology. Treatment methods were histology dependent.
MAIN OUTCOME MEASURES: The time between the onset of otalgia and the tumor diagnosis was recorded. Overall treatment outcomes were reviewed.
RESULTS: The period between the onset of otalgia and tumor diagnosis ranged from 4-21 months with a mean of 7.5 months. Adenoid cystic carcinoma was the most commonly seen tumor in this series of patients.
CONCLUSIONS: The infratemporal fossa is a relatively protected region that may be the site of malignant neoplasms causing the isolated symptom of otalgia.